Testing laboratory company Eurofins has acquired a majority stake in Bio-EC, Spincontrol and Genex, part of Bio-EC / Spincontrol Group.
Eurofins, Cosmetics and Personal Care (C&PC) and Bio-EC, Spincontrol and Genex provide testing solutions for cosmetics, food supplements and medical devices.
The French-based companies are headquartered in Paris and Tours, with three facilities in France and Canada, employing 58 people.
Related: Eurofins Assurance Acquires Sisthema
With 24 years of experience, Bio-EC features expertise in ex vivo models and mechanisms and in vitro toxicology services. It also features new clinical facilities in Paris, including an in-house Raman spectroscopy. Bio-EC, meanwhile, is involved in several research and innovation projects and channels its expertise into offering new models and methods each year.
Clinical efficacy studies companies, Spincontrol France and Spincontrol Canada will allow Eurofins C&PC to expand upon existing clinical capabilities, ad-hoc testing protocols and emotion studies, and open access to in-house image analysis and new shooting technologies. The acquisition will also bring Eurofins' companies closer to local and regional customers in France and Canada.
Genex's expertise in cosmetogenomics will support Eurofins C&PC in offering new gene expression monitoring to its customers to identify product effects and reveal new targets and mechanisms.
